Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavio M Pontes-Neto

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Hypertension|October 8, 2020
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trialJatinder S Minhas, Xia Wang, Richard I Lindley, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Cardiovascular Statistics - Brazil 2020Gláucia Maria Moraes de Oliveira, Luisa Campos Caldeira Brant, Carisi Anne Polanczyk, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 3, 2015
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentYining Huang, Vijay K Sharma, Thompson Robinson, et al.
Stroke|June 17, 2017
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)Thompson G Robinson, Xia Wang, Hisatomi Arima, et al.
Eclinicalmedicine|February 23, 2023
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trialChen Chen, Menglu Ouyang, Sheila Ong, et al.
Neurology|November 14, 2024
Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED StudyYanan Wang, Toshiki Maeda, Shoujiang You, et al.
The New England Journal of Medicine|May 11, 2016
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic StrokeCraig S Anderson, Thompson Robinson, Richard I Lindley, et al.
The Lancet Regional Health. Western Pacific|September 10, 2025
Surgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 studyXin Hu, Menglu Ouyang, Jianguo Xu, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Hypertension|October 8, 2020
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trialJatinder S Minhas, Xia Wang, Richard I Lindley, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Cardiovascular Statistics - Brazil 2020Gláucia Maria Moraes de Oliveira, Luisa Campos Caldeira Brant, Carisi Anne Polanczyk, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 3, 2015
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentYining Huang, Vijay K Sharma, Thompson Robinson, et al.
Stroke|June 17, 2017
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)Thompson G Robinson, Xia Wang, Hisatomi Arima, et al.
Eclinicalmedicine|February 23, 2023
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trialChen Chen, Menglu Ouyang, Sheila Ong, et al.
Neurology|November 14, 2024
Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED StudyYanan Wang, Toshiki Maeda, Shoujiang You, et al.
The New England Journal of Medicine|May 11, 2016
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic StrokeCraig S Anderson, Thompson Robinson, Richard I Lindley, et al.
The Lancet Regional Health. Western Pacific|September 10, 2025
Surgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 studyXin Hu, Menglu Ouyang, Jianguo Xu, et al.
Pageof 7